Venture Capital and the European Biotechnology Industry

by William Bains.

Published November 2008 by Palgrave Macmillan Ltd., ISBN 978-0-230-21719-5

3i . . 36
AbCam . . 6, 188
Abgenix . . 78
Acambis . . 30, 60
Actelion . . 60
Advent . . 26, 27
Affymetrix . . 54, 181
Air Products . . 27
Alizyme . . 107, 196
Amedis Pharmaceuticals . . 100, 137
Amgen . . 20, 25, 54, 60, 177
. and EPO . 6
Amylin . . 28
AquaPharm Biodiscovery . . 59
Arakis . . 132 - 3
Ardana Bioscience . . 107
Argenta . . 119
Ark Therapeutics . . 13, 107
Arrow Therapeutics . . 131
Artemis Inc . . 180
Athena Neurosciences . . 70
Atugen . . 180
Aviron . . 70
Avlar Bioventures . . 9, 13
Basilea . . 60
BIL . see Biotechnology Investments Ltd. .
Biofocus . . 107, 119
Biofusion . . 75
Biogen . . 13, 20, 25-8, 37, 60
. history . 25
Biotechnology Investments Ltd. . . 26, 29, 46, 154
Biovex . . 28
Biovitrum . . 85
British and Commonwealth Shipping . 27
British Biotechnology Ltd. . . 20, 182
British Technology Group . . 27, 60
Cambridge Antibody Technology . 7, 60, 78
Cambridge Life Sciences . . 26
Camitro . . 63
Cantab Pharmaceuticals . . 28
Celera . . 82, 3
Celgene . . 20, 84
Cell Genesys . . 84
Celltech . . 5, 20, 26-7, 85, 182
Cetus . . 5
Charterhouse Japet . . 120
Chiron . . 5, 25
Chiroscience . . 13, 18, 121
Ciba Geigy . . 27
Cogent . . 26
CV Therapeutics . . 70
Cyclacel . . 28, 130-1
Cytomyx . . 107
Darwin Moleculer . . 121
DNAX . . 47
Domantis . . 76
EIF . see European Investment Fund .
Eli Lilly . . 5, 27
Entelos . . 63
Ethical Pharmaceuticals . . 28
European Investment Fund (EIF) . 13, 185-6
Evolutec . . 107
Exelesis . . 78,180
Gene Logic . . 78, 84
Genentech . . 5, 9, 20, 25, 54, 60, 177
Genentech . capital used . 115
Genentech . IPO . 75
Genentech . lawsuits . 64
Genetics Institute . . 78
GenMab . . 85
Genzyme . . 20, 25, 60
Geron . . 115 - 6
Gilead . . 20, 60
GIMV . . 36

Grand Metropolitan . . 27
Henderson Moreley . . 107
Human Genome Sciences Inc . . 122
IDM . . 28
Incyte . . 78
Innogenetics . . 60
Integrated Genetics . . 78
Intercytex . . 129
IP Group . . 75, 83
KuDoS . . 76
Lexicon Genetics . . 78
Lynx Therapeutics . . 78
Maxim Pharmaceuticals . . 84
Maxygen . . 84
Medarex . . 84
Medimmune . . 25
Medisense . . 76
Mercator Genetics . . 78
Merlin Biosciences . . 9, 13, 40
Merlin Ventures . . 9
Micromet . . 28
Microscience . . 131
Millennium Pharmaceuticals . . 25, 78
Monsanto . . 27
Morphochem . . 119
Morphosys . . 60
Myriad . . 78
Nereus Pharmaceuticals . . 59
NiCox . . 85
Nordic Bone . . 28
Novo Nordisk . . 5, 17, 182
Onyx Pharmaceuticals . . 70
Oxford Ancestors . . 6
Oxford Biomedica . . 107
Oxford Glycosciences . . 78
Paradigm Genetics . . 78
Paradigm Therapeutics . . 137
Peptech . . 7
Peptide therapeutics . . 60
Pfizer . patents . 60
Pharmaceutical Proteins . . 28
Pharmagene . . 107
Prutech . . 26
ReNeuron . . 100, 107, 115-6
Ribozyme Pharmaceuticals . . 180
Ricera . . 119
Schering Plough . . 27
Scotgen . . 28
Sequana Therapeutics . . 78
Sequenom . . 38
Serono . . 17, 25, 60, 182
Serono . History . 5
Skye Pharma . . 120
Small Molecule Therapeutics Inc . 119
Soffinova . . 94
Solexa . . 13, 76
Sosei . . 132 - 3
Standard Oil . . 27
Stem Cell Sciences . . 115
Symyx . . 70
Synairgen . . 196
Technical Development Capital Ltd . 26
Technostart . . 9
Tegenero . . 165
Tularik . . 70
UCB-Celltech . see also Celltech . 25
VasTox . . 167, 196
Vectura . . 107
Vernalis . . 20, 30, 60, 134
Versant . . 70
Vysis . . 78
Xcyte . . 28, 130
Xcyte . . 130